Comment of long-acting lanreotide inducing clinical and biochemical remission of acromegaly caused by disseminated GHRH secreting carcinoid

J Clin Endocrinol Metab. 1999 May;84(5):1761-2. doi: 10.1210/jcem.84.5.5677-5.
No abstract available

Publication types

  • Case Reports
  • Letter
  • Comment

MeSH terms

  • Acromegaly / drug therapy*
  • Acromegaly / etiology
  • Adult
  • Antineoplastic Agents / therapeutic use*
  • Carcinoid Tumor / complications
  • Carcinoid Tumor / metabolism*
  • Carcinoid Tumor / secondary
  • Growth Hormone-Releasing Hormone / metabolism*
  • Humans
  • Male
  • Peptides, Cyclic / therapeutic use*
  • Somatostatin / analogs & derivatives*
  • Somatostatin / therapeutic use
  • Thyroid Neoplasms / complications
  • Thyroid Neoplasms / metabolism*
  • Thyroid Neoplasms / secondary

Substances

  • Antineoplastic Agents
  • Peptides, Cyclic
  • lanreotide
  • Somatostatin
  • Growth Hormone-Releasing Hormone